Thermo Fisher Scientific, Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 636.30 USD | +2.79% |
|
+4.81% | +9.81% |
| 01-20 | Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $710 From $685, Maintains Buy Rating | MT |
| 01-15 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Capitalization | 239B 204B 190B 178B 330B 21,898B 354B 2,178B 862B 10,349B 896B 878B 37,804B | P/E ratio 2025 * |
35.7x | P/E ratio 2026 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise value | 267B 229B 212B 199B 369B 24,489B 395B 2,435B 964B 11,574B 1,003B 982B 42,276B | EV / Sales 2025 * |
6.04x | EV / Sales 2026 * | 5.65x |
| Free-Float |
86.06% | Yield 2025 * |
0.26% | Yield 2026 * | 0.27% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | +2.79% | ||
| 1 week | +4.81% | ||
| Current month | +9.81% | ||
| 1 month | +12.06% | ||
| 3 months | +17.00% | ||
| 6 months | +53.42% | ||
| Current year | +9.81% |
| 1 week | 606 |  | 637.98 |
| 1 month | 565.75 | | 637.98 |
| Current year | 577 | | 637.98 |
| 1 year | 385.46 | | 637.98 |
| 3 years | 385.46 | | 637.98 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 119.75 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 14/10/2009 |
| Director of Finance/CFO | 59 | 31/07/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 08/11/2006 |
Marc Casper
CHM | Chairman | 58 | 25/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 25/05/2009 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.59% | 7.43% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.79% | +4.81% | +13.70% | +7.18% | 233B | |
| -0.71% | -6.79% | -11.63% | +103.95% | 187B | |
| +3.29% | +2.76% | +1.55% | -11.79% | 166B | |
| +0.56% | -2.58% | -7.04% | +101.03% | 135B | |
| -2.00% | -6.65% | -16.26% | -9.37% | 58.28B | |
| +2.01% | +1.55% | +22.01% | +7.38% | 48.43B | |
| +2.90% | -4.48% | -5.15% | -10.36% | 38.51B | |
| +2.41% | +1.81% | +8.13% | +10.46% | 36.88B | |
| +2.88% | -4.33% | -4.30% | +21.46% | 35.91B | |
| -0.86% | -6.20% | -17.39% | -42.74% | 34.23B | |
| Average | +0.84% | -4.08% | -1.64% | +17.72% | 97.26B | |
| Weighted average by Cap. | +1.02% | -3.67% | -0.22% | +32.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.28B 37.86B 35.14B 32.96B 61.14B 4,056B 65.47B 403B 160B 1,917B 166B 163B 7,001B | 46.58B 39.83B 36.97B 34.67B 64.33B 4,267B 68.88B 424B 168B 2,017B 175B 171B 7,366B |
| Net income | 6.72B 5.74B 5.33B 5B 9.28B 615B 9.93B 61.19B 24.21B 291B 25.19B 24.67B 1,062B | 7.39B 6.32B 5.86B 5.5B 10.2B 677B 10.92B 67.29B 26.63B 320B 27.7B 27.13B 1,168B |
| Net Debt | 28.29B 24.18B 22.45B 21.06B 39.06B 2,591B 41.83B 258B 102B 1,225B 106B 104B 4,473B | 23.96B 20.49B 19.02B 17.84B 33.09B 2,195B 35.43B 218B 86.37B 1,037B 89.86B 88.02B 3,789B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 636.30 $ | +2.79% | 3,179,728 |
| 20/01/26 | 619.01 $ | +0.05% | 3,108,847 |
| 16/01/26 | 618.72 $ | -0.95% | 2,880,991 |
| 15/01/26 | 624.65 $ | +0.45% | 2,541,472 |
| 14/01/26 | 621.83 $ | +2.43% | 2,460,459 |
Delayed Quote Nyse, January 21, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition